Skip to content
Frontiers
Search

Frontiers in Nuclear Medicine

1K
Citations
0
Views
0
Downloads
Submit manuscript

Explore open access research in nuclear medicine, advancing imaging, dosimetry, radiopharmacy, radiotherapy and data‑driven diagnostics.

Frontiers in Nuclear Medicine is a multidisciplinary journal that advances the use of nuclear medicine in diagnostics and therapeutics as an essential part of patient care. Led by Field Chief Editor Prof Adriaan A. La...

About the journal

  • Submit your research

    Start your submission and get more impact for your research by publishing with us.

  • Author guidelines

    Ready to publish? Check our author guidelines for everything you need to know about submitting, from choosing a journal and section to preparing your manuscript.

  • Editor guidelines

    Reviewing a manuscript? See our editor guidelines for everything you need to know about the Frontiers peer review process.

  • Peer review

    Our rigorous and transparent peer review combines expert assessment with constructive dialogue to strengthen your manuscript.

  • Publishing fees

    Article processing charges apply to articles accepted for publication by our external editors after rigorous peer review.

Editors

View all

Adriaan Anthonius Lammertsma

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen

Netherlands

Editor-in-Chief

Alberto Cuocolo

Department of Advanced Biomedical Sciences, School of Medicine and Surgery, University of Naples Federico II

Italy

Specialty Chief Editor

PET and SPECT

Charalampos Tsoumpas

University Medical Center Groningen

Netherlands

Specialty Chief Editor

Physics and Data Analysis

Flavio Forrer

Cantonal Hospital St.Gallen

Switzerland

Specialty Chief Editor

Radionuclide Therapy

Mario Petretta

University of Naples Federico II

Italy

Specialty Chief Editor

PET and SPECT

Mark Konijnenberg

Erasmus Medical Center

Netherlands

Specialty Chief Editor

Dosimetry and Radiation Safety

Shozo Furumoto

Tohoku University

Japan

Specialty Chief Editor

Radiopharmacy and Radiochemistry

117 editors · 0 reviewers

Articles

View all (50)

Research topics

View all (14)

About the journal

Scope

Frontiers in Nuclear Medicine is a multidisciplinary journal that advances the use of nuclear medicine in diagnostics and therapeutics as an essential part of patient care. Led by Field Chief Editor Prof Adriaan A. Lammertsma (University Medical Center Groningen, Netherlands) and an outstanding international editorial board, Frontiers in Nuclear Medicine publishes research that is dedicated to the application and development of nuclear medicine techniques for diagnostic and/or therapeutic purposes across all major subspecialties involved, including: dosimetry and radiation safety PET and SPECT physics and data analysis radiomics and artificial intelligence radionuclide therapy radiopharmacy and radiochemistry. Frontiers in Nuclear Medicine welcomes research studies that include advances in technology, diagnostics studies, AI applied to image interpretation, as well as studies on radionuclide therapy. In addition, the journal welcomes studies on the synthesis and evaluation of novel radiotracers, studies that aim to quantify radiotracer uptake, as well as novel multi-disciplinary and cross-disciplinary studies in nuclear medicine. Finally, research and clinical practice of nuclear medicine in disciplines such as neurology, oncology, cardiology, and inflammatory diseases are encouraged, together with studies in which nuclear medicine methodology is used for drug development and precision medicine. The journal also welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being. Manuscripts that focus solely on the diagnosis or therapy of diseases without applying nuclear medicine techniques are not suitable for publication in this journal. In addition, studies that do not utilize or discuss the application of nuclear medicine methods in their research are not within the scope of this journal. Frontiers in Nuclear Medicine is committed to advancing developments in the field of nuclear medicine by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.

Aims

Frontiers in Nuclear Medicine is a multidisciplinary journal that advances the use of nuclear medicine in diagnostics and therapeutics as an essential part of patient care.

Led by Field Chief Editor Prof Adriaan A. Lammertsma (University Medical Center Groningen, Netherlands) and an outstanding international editorial board, Frontiers in Nuclear Medicine publishes research that is dedicated to the application and development of nuclear medicine techniques for diagnostic and/or therapeutic purposes across all major subspecialties involved, including:

dosimetry and radiation safety

PET and SPECT

physics and data analysis

radiomics and artificial intelligence

radionuclide therapy

radiopharmacy and radiochemistry.

Frontiers in Nuclear Medicine welcomes research studies that include advances in technology, diagnostics studies, AI applied to image interpretation, as well as studies on radionuclide therapy. In addition, the journal welcomes studies on the synthesis and evaluation of novel radiotracers, studies that aim to quantify radiotracer uptake, as well as novel multi-disciplinary and cross-disciplinary studies in nuclear medicine. Finally, research and clinical practice of nuclear medicine in disciplines such as neurology, oncology, cardiology, and inflammatory diseases are encouraged, together with studies in which nuclear medicine methodology is used for drug development and precision medicine.

The journal also welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.

Manuscripts that focus solely on the diagnosis or therapy of diseases without applying nuclear medicine techniques are not suitable for publication in this journal. In addition, studies that do not utilize or discuss the application of nuclear medicine methods in their research are not within the scope of this journal.

Frontiers in Nuclear Medicine is committed to advancing developments in the field of nuclear medicine by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.

Source: https://www.frontiersin.org/journals/nuclear-medicine/about

ISSN
2673-8880
Editor-in-Chief
Adriaan Anthonius Lammertsma (Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands) — Field Chief Editor
Established
2026

Sections

  • Dosimetry and Radiation Safety

    Official section page: https://www.frontiersin.org/journals/nuclear-medicine/sections/dosimetry-and-radiation-safety

  • PET and SPECT

    Official section page: https://www.frontiersin.org/journals/nuclear-medicine/sections/pet-and-spect

  • Physics and Data Analysis

    Official section page: https://www.frontiersin.org/journals/nuclear-medicine/sections/physics-and-data-analysis

  • Radiomics and Artificial Intelligence

    Official section page: https://www.frontiersin.org/journals/nuclear-medicine/sections/radiomics-and-artificial-intelligence

  • Radionuclide Therapy

    Official section page: https://www.frontiersin.org/journals/nuclear-medicine/sections/radionuclide-therapy

  • Radiopharmacy and Radiochemistry

    Official section page: https://www.frontiersin.org/journals/nuclear-medicine/sections/radiopharmacy-and-radiochemistry

Article types accepted

  • Original Research
  • Systematic Review
  • Methods
  • Review
  • Mini Review
  • Policy and Practice Reviews
  • Hypothesis and Theory
  • Perspective
  • Clinical Trial
  • Case Report
  • Community Case Study
  • Classification
  • Curriculum
  • Instruction
  • and Pedagogy
  • Data Report
  • Policy Brief
  • Brief Research Report
  • General Commentary
  • Opinion
  • Correction
  • Editorial
  • Registered Report
  • Technology and Code
  • Study Protocol
  • FAIR² Data

Fees and currencies

  • Article processing charges (official)
  • - Category A: CHF 2,195 — Original Research, Systematic Review, Methods, Review, Policy and Practice Reviews, Hypothesis and Theory, Clinical Trial, Classification, Registered Report, Technology and Code, Study Protocol
  • - Category B: CHF 1,750 — Mini Review, Perspective, Case Report, Community Case Study, Curriculum, Instruction, and Pedagogy, Data Report, Policy Brief, Brief Research Report, General Commentary, Opinion
  • - Category C: CHF 0 — Correction, Editorial
  • Currency: CHF

Fees are charged only after acceptance. Waivers and discounts are available for authors with limited funding.

Fees and waivers policy

Editorial policies

Peer review

  • Official peer-review process: https://www.frontiersin.org/about/peer-review

Publication ethics

  • Policies and publication ethics: https://www.frontiersin.org/guidelines/policies-and-publication-ethics

Indexing

  • Bielefeld Academic Search Engine (BASE)
  • CNKI Scholar
  • CLOCKSS
  • Crossref
  • Dimensions
  • Chinese Academy of Sciences GoOA
  • OpenAIRE
  • EBSCO
  • DOAJ
  • Scopus
  • PubMed
  • PubMed Central (PMC)
  • Web of Science Emerging Sources Citation Index (ESCI)
  • Committee on Publication Ethics (COPE)
  • ProQuest

Affiliated societies

  • Committee on Publication Ethics

Source: https://www.frontiersin.org/journals/nuclear-medicine/about

Instructions for authors

Accepted article types

  • Original Research (fee category A)
  • Systematic Review (fee category A)
  • Methods (fee category A)
  • Review (fee category A)
  • Mini Review (fee category B)
  • Policy and Practice Reviews (fee category A)
  • Hypothesis and Theory (fee category A)
  • Perspective (fee category B)
  • Clinical Trial (fee category A)
  • Case Report (fee category B)
  • Community Case Study (fee category B)
  • Classification (fee category A)
  • Curriculum, Instruction, and Pedagogy (fee category B)
  • Data Report (fee category B)
  • Policy Brief (fee category B)
  • Brief Research Report (fee category B)
  • General Commentary (fee category B)
  • Opinion (fee category B)
  • Correction (fee category C)
  • Editorial (fee category C)
  • Registered Report (fee category A)
  • Technology and Code (fee category A)
  • Study Protocol (fee category A)
  • FAIR² Data

Author guidelines

  • https://www.frontiersin.org/journals/nuclear-medicine/for-authors/author-guidelines

Peer review

  • https://www.frontiersin.org/about/peer-review

Journal metrics

Citation score
3.1
Articles
50
Total views
0
Downloads
0
Citations
1,015

Internal metrics, calculated on this platform and maintained by the editorial office.

Official bibliometric indicators

Impact factor
2.5
CiteScore
3.1
Citations
1015
Acceptance rate
33
Time to publication
98

Source: official publisher page · retrieved 2026-10-16

Some values were updated by the editorial office on 2026-10-22.